189 related articles for article (PubMed ID: 18496560)
61. Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors.
Gonzalez-Murillo A; Lozano ML; Montini E; Bueren JA; Guenechea G
Blood; 2008 Oct; 112(8):3138-47. PubMed ID: 18684860
[TBL] [Abstract][Full Text] [Related]
62. Leukemic predisposition of pSca-1/Cb2 transgenic mice.
Joosten M; Valk PJ; Jordà MA; Vankan-Berkhoudt Y; Verbakel S; van den Broek M; Beijen A; Löwenberg B; Delwel R
Exp Hematol; 2002 Feb; 30(2):142-9. PubMed ID: 11823049
[TBL] [Abstract][Full Text] [Related]
63. Retroviral gene therapy: safety issues and possible solutions.
Yi Y; Hahm SH; Lee KH
Curr Gene Ther; 2005 Feb; 5(1):25-35. PubMed ID: 15638709
[TBL] [Abstract][Full Text] [Related]
64. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.
Baum C; Kustikova O; Modlich U; Li Z; Fehse B
Hum Gene Ther; 2006 Mar; 17(3):253-63. PubMed ID: 16544975
[TBL] [Abstract][Full Text] [Related]
65. Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.
Heckl D; Schwarzer A; Haemmerle R; Steinemann D; Rudolph C; Skawran B; Knoess S; Krause J; Li Z; Schlegelberger B; Baum C; Modlich U
Mol Ther; 2012 Jun; 20(6):1187-95. PubMed ID: 22472950
[TBL] [Abstract][Full Text] [Related]
66. Retroviral insertional mutagenesis can contribute to immortalization of mature T lymphocytes.
Newrzela S; Cornils K; Heinrich T; Schläger J; Yi JH; Lysenko O; Kimpel J; Fehse B; von Laer D
Mol Med; 2011; 17(11-12):1223-32. PubMed ID: 21826372
[TBL] [Abstract][Full Text] [Related]
67. A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration.
Loew R; Meyer Y; Kuehlcke K; Gama-Norton L; Wirth D; Hauser H; Stein S; Grez M; Thornhill S; Thrasher A; Baum C; Schambach A
Gene Ther; 2010 Feb; 17(2):272-80. PubMed ID: 19865181
[TBL] [Abstract][Full Text] [Related]
68. Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?
Staal FJ; Pike-Overzet K; Ng YY; van Dongen JJ
Leukemia; 2008 Oct; 22(10):1849-52. PubMed ID: 18769449
[TBL] [Abstract][Full Text] [Related]
69. Evaluating a ligation-mediated PCR and pyrosequencing method for the detection of clonal contribution in polyclonal retrovirally transduced samples.
Brugman MH; Suerth JD; Rothe M; Suerbaum S; Schambach A; Modlich U; Kustikova O; Baum C
Hum Gene Ther Methods; 2013 Apr; 24(2):68-79. PubMed ID: 23384086
[TBL] [Abstract][Full Text] [Related]
70. Retroviral vectors: post entry events and genomic alterations.
Nowrouzi A; Glimm H; von Kalle C; Schmidt M
Viruses; 2011 May; 3(5):429-55. PubMed ID: 21994741
[TBL] [Abstract][Full Text] [Related]
71. Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis.
Knight S; Collins M; Takeuchi Y
Curr Gene Ther; 2013 Jun; 13(3):211-27. PubMed ID: 23590635
[TBL] [Abstract][Full Text] [Related]
72. Development of retroviral vectors for insertional mutagenesis in medaka haploid cells.
Lin F; Liu Q; Yuan Y; Hong Y
Gene; 2015 Dec; 573(2):296-302. PubMed ID: 26192464
[TBL] [Abstract][Full Text] [Related]
73. Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanisms of insertional activation.
Kung HJ; Boerkoel C; Carter TH
Curr Top Microbiol Immunol; 1991; 171():1-25. PubMed ID: 1814689
[No Abstract] [Full Text] [Related]
74. Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency.
Poletti V; Charrier S; Corre G; Gjata B; Vignaud A; Zhang F; Rothe M; Schambach A; Gaspar HB; Thrasher AJ; Mavilio F
Mol Ther Methods Clin Dev; 2018 Jun; 9():257-269. PubMed ID: 29707600
[TBL] [Abstract][Full Text] [Related]
75. Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis.
Du Y; Spence SE; Jenkins NA; Copeland NG
Blood; 2005 Oct; 106(7):2498-505. PubMed ID: 15961513
[TBL] [Abstract][Full Text] [Related]
76. Retroviral insertion mutagenesis in mice as a comparative oncogenomics tool to identify disease genes in human leukemia.
Touw IP; Erkeland SJ
Mol Ther; 2007 Jan; 15(1):13-9. PubMed ID: 17164770
[TBL] [Abstract][Full Text] [Related]
77. Long-term vector integration site analysis following retroviral mediated gene transfer to hematopoietic stem cells for the treatment of HIV infection.
Hayakawa J; Washington K; Uchida N; Phang O; Kang EM; Hsieh MM; Tisdale JF
PLoS One; 2009; 4(1):e4211. PubMed ID: 19148292
[TBL] [Abstract][Full Text] [Related]
78. Retroviral determinants of leukemogenesis.
Athas GB; Starkey CR; Levy LS
Crit Rev Oncog; 1994; 5(2-3):169-99. PubMed ID: 7849085
[TBL] [Abstract][Full Text] [Related]
79. Long-distance effects of insertional mutagenesis.
Singhal R; Deng X; Chenchik AA; Kandel ES
PLoS One; 2011 Jan; 6(1):e15832. PubMed ID: 21246045
[TBL] [Abstract][Full Text] [Related]
80. Oncogenes, molecular medicine, and bone marrow transplantation.
Hijiya N; Gewirtz AM
J Hematother; 1992; 1(4):369-78. PubMed ID: 1345679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
